Targeting gut brain-signaling to reduce cocaine seeking behaviors

针对肠道大脑信号传导以减少可卡因寻求行为

基本信息

  • 批准号:
    10733638
  • 负责人:
  • 金额:
    $ 67.16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-01 至 2028-06-30
  • 项目状态:
    未结题

项目摘要

Project Summary Pathological substance use disorders are devastating psychiatric conditions that lead to patterns of increasing and out of control substance use. These disorders account for significant morbidity and mortality amongst patients and inflict untold costs on their families and loved ones as well as society at large. Of these disorders, pathological use of cocaine and other psychostimulants accounts for a significant proportion of morbidity and mortality. Despite tremendous advances in understanding of the neurobiology of stimulant use disorders, there are no FDA-approved pharmacotherapies for stimulant use disorders. In treating patients with stimulant use disorder, the largest hurdle to overcome is in preventing drug relapse. In recent years there has been a growing understanding that a number of systems outside of the brain can play a critical role in shaping brain and behavior. Among these is the resident population of bacteria in the intestinal tract – collectively referred to as the gut microbiome. Extensive research now demonstrates that changes in the gut microbiome play a critical role in both normal brain function, as well as in the development of pathological states. In our own lab we have previously published that acute depletion of the microbiome can alter the rewarding effects of cocaine and affect gene expression changes in the brain. More recently, we have begun investigating how depleting the microbiome with antibiotics affects the persistence of behavioral and brain gene expression changes in animal models of relapse. We find that animals that lack a complex microbiome have increased cocaine seeking behaviors after a prolonged period of abstinence. Genome-wide RNA-sequencing analyses demonstrate that these animals have robust changes in gene expression in important striatal gene networks that affect synaptic plasticity and behavior. Additional analyses demonstrate epigenetic changes in chromatin structure. Importantly, behavioral and molecular effects of microbiome depletion can be largely reversed by replenishment of specific bacterially derived small molecules. In this grant we will work in two comprehensive Aims to clarify the specificity and mechanisms of these effects and will work to further targeting the gut microbiome and its molecular byproducts. Aim 1 will define temporal specificity of microbiome depletion effects on drug seeking behaviors with targeted microbiome depletions and reconstitutions at different phases of behavior. Behavioral studies will be coupled with molecular analyses of synaptic plasticity related transcriptional and epigenetic effects. Additional analyses of microbiome composition will define bacterial populations associated with increased drug seeking. Aim 2 will further clarify the role of individual microbiome- derived small molecules in driving these behavioral and molecular changes. These studies will provide critical mechanistic insight into gut-brain signaling in a model of cocaine use disorder and will lay the foundation for tractable translational research going forward.
项目摘要 病理性物质使用障碍是毁灭性的精神状况,导致增加的模式, 以及滥用药物这些疾病占显著的发病率和死亡率, 这不仅对患者造成了巨大的伤害,而且给他们的家庭和亲人以及整个社会造成了难以估量的代价。在这些疾病中, 可卡因和其他精神兴奋剂的病理性使用占发病率的很大比例, mortality.尽管对兴奋剂使用障碍的神经生物学理解有了巨大的进步, 没有FDA批准的兴奋剂使用障碍的药物治疗。在治疗使用兴奋剂的患者时 要克服的最大障碍是防止复吸。近年来, 越来越多的人认识到,大脑以外的一些系统在塑造大脑方面发挥着关键作用。 和行为。其中包括肠道中的常驻细菌群-统称为 作为肠道微生物组。广泛的研究现在表明,肠道微生物组的变化起着重要作用。 在正常的大脑功能以及病理状态的发展中起着关键作用。在我们自己的实验室里 我们之前已经发表过,微生物组的急性消耗可以改变可卡因的奖励作用。 并影响大脑中基因表达的变化。最近,我们开始研究 抗生素的微生物组影响行为和大脑基因表达变化的持续性, 复发的动物模型。我们发现,缺乏复杂微生物组的动物会增加可卡因 在长期禁欲后寻求行为。全基因组RNA测序分析 表明这些动物在重要的纹状体基因网络中的基因表达发生了强烈的变化, 影响突触的可塑性和行为。其他分析表明染色质的表观遗传变化 结构重要的是,微生物组消耗的行为和分子效应可以通过以下方式在很大程度上逆转: 补充特定细菌衍生的小分子。在这一补助金,我们将在两个全面的工作 旨在阐明这些作用的特异性和机制,并将致力于进一步靶向肠道 微生物组及其分子副产物。目标1将定义微生物组消耗效应的时间特异性 在不同阶段的药物寻求行为与目标微生物组消耗和重建 行为行为研究将与突触可塑性相关的分子分析相结合。 转录和表观遗传效应。对微生物组组成的其他分析将确定细菌 与寻求毒品有关的人口增加。目标2将进一步阐明个体微生物组的作用- 衍生小分子来驱动这些行为和分子变化。这些研究将提供关键的 在可卡因使用障碍模型中对肠脑信号传导的机械见解,并将为 可操作的转化研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Drew Kiraly其他文献

Drew Kiraly的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Drew Kiraly', 18)}}的其他基金

Targeting the host metabolome to reverse drug-induced epigenetic changes
靶向宿主代谢组以逆转药物诱导的表观遗传变化
  • 批准号:
    10881008
  • 财政年份:
    2020
  • 资助金额:
    $ 67.16万
  • 项目类别:
Targeting the host metabolome to reverse drug-induced epigenetic changes
靶向宿主代谢组以逆转药物诱导的表观遗传变化
  • 批准号:
    10044659
  • 财政年份:
    2020
  • 资助金额:
    $ 67.16万
  • 项目类别:
Targeting the host metabolome to reverse drug-induced epigenetic changes
靶向宿主代谢组以逆转药物诱导的表观遗传变化
  • 批准号:
    10205016
  • 财政年份:
    2020
  • 资助金额:
    $ 67.16万
  • 项目类别:
Targeting the host metabolome to reverse drug-induced epigenetic changes
靶向宿主代谢组以逆转药物诱导的表观遗传变化
  • 批准号:
    10666547
  • 财政年份:
    2020
  • 资助金额:
    $ 67.16万
  • 项目类别:
Targeting the host metabolome to reverse drug-induced epigenetic changes
靶向宿主代谢组以逆转药物诱导的表观遗传变化
  • 批准号:
    10408789
  • 财政年份:
    2020
  • 资助金额:
    $ 67.16万
  • 项目类别:
Neuroimmune modulation of neuronal function during cocaine conditioning
可卡因调理过程中神经元功能的神经免疫调节
  • 批准号:
    10015251
  • 财政年份:
    2019
  • 资助金额:
    $ 67.16万
  • 项目类别:
Dissecting the role of granulocyte-colony stimulating factor in cocaine-mediated behavioral plasticity
剖析粒细胞集落刺激因子在可卡因介导的行为可塑性中的作用
  • 批准号:
    9370396
  • 财政年份:
    2017
  • 资助金额:
    $ 67.16万
  • 项目类别:
Dissecting the role of granulocyte-colony stimulating factor in cocaine-mediated behavioral plasticity
剖析粒细胞集落刺激因子在可卡因介导的行为可塑性中的作用
  • 批准号:
    9492785
  • 财政年份:
    2017
  • 资助金额:
    $ 67.16万
  • 项目类别:
Dissecting the role of granulocyte-colony stimulating factor in cocaine-mediated behavioral plasticity
剖析粒细胞集落刺激因子在可卡因介导的行为可塑性中的作用
  • 批准号:
    10190875
  • 财政年份:
    2017
  • 资助金额:
    $ 67.16万
  • 项目类别:
Kalirin-7 is essential in cocaine signaling: focus on nucleus accumbens
Kalirin-7 在可卡因信号传导中至关重要:关注伏隔核
  • 批准号:
    8352102
  • 财政年份:
    2010
  • 资助金额:
    $ 67.16万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 67.16万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 67.16万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 67.16万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 67.16万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 67.16万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 67.16万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 67.16万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 67.16万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 67.16万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 67.16万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了